Gillian M. Fenton, Esq., CLP recently became the founder and managing director of LST Strategies LLC, a specialty law practice dedicated to life science transactions (https://lifesciencetransactions.com). She is also a Practitioner in Residence at the Center for Intellectual Property x Innovation Policy (https://cip2.gmu.edu/), hosted by George Mason University. Previously, she served GSK (GlaxoSmithKline) as Vaccines Special Counsel for Innovation and Government Collaborations. Gillian supported a wide variety of international business development transactions, R&D collaborations and strategic alliances to feed the pipeline for GSK’s vaccines and infectious diseases business segment. She also negotiated and managed GSK Vaccines’ R&D U.S. Government Contracts, patent licenses, and scientific collaborations with NIH/NIAID, BARDA, DARPA, CARB-X and NIIMBL. Before joining GSK, Gillian was VP, Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields. Gillian also spent over twelve years in private practice at law firms in Boston, MA and Washington, DC.
Gillian is an active member of the Licensing Executives Society (LES, USA & Canada), and served as the society President in 2020-2021. Gillian’s contributions to LES and to the field of licensing were recognized with the society’s Frank Barnes Award in October 2022. She has been listed in the IAM 300 since October 2023. Gillian has published several manuscripts on the Bayh-Dole Act and speaks frequently on this and other topics of interest to the licensing and dealmaking community. She is also the course chair for the LES IP Licensing Basics course.
Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College. Admissions: MA, MD, DC. Registered U.S. Patent Attorney.
